Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is currently trading at 31.26 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Biofil Chemicals & Pharmaceuticals Limited (BCPL) primarily manufactures and trades in pharmaceutical products, leveraging two divisions: Pharmaceuticals and Chemicals. Initially a private company, BCPL transitioned to public status in 1992 and has since expanded into manufacturing a variety of pharmaceutical formulations, including injections and syrups. A significant partnership with HLL Lifecare Limited has positioned BCPL as a key player in pharmaceutical manufacturing, especially for government contracts involving essential medications like Iron and Folic Acid tablets. The company has diversified its operations by entering the plastic products market, primarily for pharmaceutical packaging, enhancing its vertical integration and sales offerings.

Over the past 52 weeks, Biofil Chemicals & Pharmaceuticals Ltd has traded between a low of ₹25.60 and a high of ₹46.82. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Biofil Chemicals & Pharmaceuticals Ltd has a market capitalization of approximately 52.06. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Biofil Chemicals & Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 108.46 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 52.06 Cr, Biofil Chemicals & Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Biofil Chemicals & Pharmaceuticals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Biofil Chemicals & Pharmaceuticals Ltd is 108.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.